Raymond James Downgrades Compass Therapeutics (CMPX) to Market Perform

April 28, 2026 6:24 AM

(Updated - April 28, 2026 6:24 AM EDT)

Raymond James analyst Sean McCutcheon downgraded Compass Therapeutics (NASDAQ: CMPX) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found